cancer-immunotherapy

Documents about cancer-immunotherapy

• Perceptions on Expected Outcomes of Immunotherapy in Advanced Cancer Patients With Poor Performance Status#398323ClinicalTrials.gov
• Neoadjuvant Treatment Modalities in Esophageal Cancer#405154ClinicalTrials.gov
• Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer#651255ClinicalTrials.gov
• Microbiome Immunotherapy Toxicity and Response Evaluation#843036ClinicalTrials.gov
• Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer#123468ClinicalTrials.gov
• Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer#123453ClinicalTrials.gov
• Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)#238124ClinicalTrials.gov
• A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions#329426ClinicalTrials.gov
• Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer#349973ClinicalTrials.gov
• Immunotherapy-related CRP Kinetics in Early and Metastatic Triple-negative Breast Cancer#366591ClinicalTrials.gov
• First-Line and Neoadjuvant Immunotherapy for Gastric Cancer#432880ClinicalTrials.gov
• Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation#454020ClinicalTrials.gov
• Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)#463716ClinicalTrials.gov
• Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer#623506ClinicalTrials.gov
• Low-dose Radiotherapy Combined With Conventional Radiotherapy After Immunotherapy Failure#272338ClinicalTrials.gov
• Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer#283036ClinicalTrials.gov
• Open Label Trial of Immunotherapy for Advanced Liver Cancer#350019ClinicalTrials.gov
• Toripalimab Combined With Definitive CCRT for LACC Patients#369836ClinicalTrials.gov
• Neoadjuvant Immunotherapy in Advanced NSCLC#474755ClinicalTrials.gov
• Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy#628546ClinicalTrials.gov
• TEIPP Immunotherapy in Patients With NSCLC#674903ClinicalTrials.gov
• Mechanisms of tumor cell evasion from NK cell-mediated killing and advances in NK cell-based cancer immunotherapy#4574Europe PMC
• Decision-making processes among patients with lung cancer considering participation in neoadjuvant immunotherapy clinical trials: A qualitative grounded theory study#205425Europe PMC
• Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant#810951ClinicalTrials.gov
• A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors#383570ClinicalTrials.gov
• Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines#256887ClinicalTrials.gov
• Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Advanced Lung Cancer#463702ClinicalTrials.gov
• Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients#801394ClinicalTrials.gov
• ATATcH Alternating Treatment Plans for Advanced Cancer#847480ClinicalTrials.gov
• CT and MRI in Prediction of Response in Patients With Gastric Cancer Following Neoadjuvant Chemotherapy and/or Immunotherapy#363611ClinicalTrials.gov
• Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients#844720ClinicalTrials.gov
• Prospective Collection of Tumor Biopsy and Plasma Samples From Cancer Patients Treated With Molecular Targeted Therapies or Immunotherapy#854611ClinicalTrials.gov
• A Study Comparing Immunotherapy Alone Versus Immunotherapy Combined With Radiotherapy in Patients With Hepatocellular Carcinoma (HCC) With Vascular Invasion#633738ClinicalTrials.gov
• Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer#121367ClinicalTrials.gov
• Toripalimab Plus Radiotherapy for Elderly Esophageal Cancer Patients Treated With Non-chemotherapy Strategy#160344ClinicalTrials.gov
• Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients#272331ClinicalTrials.gov
• Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer#272340ClinicalTrials.gov
• An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer#321710ClinicalTrials.gov
• Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer#329537ClinicalTrials.gov
• FDG PET/CT Radiomics Analyses of Lung Cancer Patients Treated With Immunotherapy#640571ClinicalTrials.gov
• Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients#674892ClinicalTrials.gov
• Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer#674894ClinicalTrials.gov
• BESPOKE Study of ctDNA Guided Immunotherapy#808104ClinicalTrials.gov
• Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial#813985ClinicalTrials.gov
• Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer#394757ClinicalTrials.gov
• Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy#806141ClinicalTrials.gov
• Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma#136344ClinicalTrials.gov
• Combination of Immunotherapy and Hyperthermia in Advanced Malignant Mesothelioma#140983ClinicalTrials.gov
• Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC#152426ClinicalTrials.gov
• NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy#181769ClinicalTrials.gov